Beta-Carotene Reduces Body Adiposity of Mice via BCMO1 by Amengual, Jaume et al.
Beta-Carotene Reduces Body Adiposity of Mice via
BCMO1
Jaume Amengual
1,2., Erwan Gouranton
3., Yvonne G. J. van Helden
4,5,6., Susanne Hessel
7, Joan Ribot
1,
Evelien Kramer
6, Beata Kiec-Wilk
8, Ursula Razny
8, Georg Lietz
9, Adrian Wyss
10, Aldona Dembinska-
Kiec
8, Andreu Palou
1, Jaap Keijer
3, Jean Franc ¸ois Landrier
3, M. Luisa Bonet
1*, Johannes von Lintig
7,2*
1Laboratory of Molecular Biology, Nutrition and Biotechnology, Universitat de les Illes Balears and CIBER de Fisiopatologı ´a de la Obesidad y Nutricio ´n (CIBERobn), Palma
de Mallorca, Spain, 2Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio United States of America, 3INRA, UMR 1260
Nutriments Lipidiques et Prevention des Maladies Me ´taboliques/Universite Aix-Marseille I et II, Marseille, France, 4Human and Animal Physiology, Wageningen University,
Wageningen, The Netherlands, 5University Maastricht, Maastricht, The Netherlands, 6RIKILT-Institute of Food Safety, Wageningen, The Netherlands, 7Institute of Biology
I, University of Freiburg, Freiburg, Germany, 8Department of Clinical Biochemistry, The Jagiellonian University Medical College, Krakow, Poland, 9School of AFRD,
Newcastle University, Newcastle upon Tyne, United Kingdom, 10DSM Nutritional Products, R&D Human Nutrition and Health, Kaiseraugst, Switzerland
Abstract
Evidence from cell culture studies indicates that b-carotene-(BC)-derived apocarotenoidsignaling molecules canmodulate the
activities of nuclear receptors that regulate many aspects of adipocyte physiology. Two BC metabolizing enzymes, the BC-
15,159-oxygenase (Bcmo1) and the BC-99,109-oxygenase (Bcdo2) are expressed in adipocytes. Bcmo1 catalyzes the conversion
of BC into retinaldehyde and Bcdo2 into b-109-apocarotenal and b-ionone. Here we analyzed the impact of BC on body
adiposity of mice. To genetically dissect the roles of Bcmo1 and Bcdo2 in this process, we usedwild-type and Bcmo1
-/- mice for
this study. In wild-typemice, BC was converted into retinoids. In contrast, Bcmo1
-/- miceshowed increased expression of Bcdo2
in adipocytes and b-109-apocarotenol accumulated as the major BC derivative. In wild-type mice, BC significantly reduced
body adiposity (by 28%), leptinemia and adipocyte size. Genome wide microarray analysis of inguinal white adipose tissue
revealed a generalized decrease of mRNA expression of peroxisome proliferator-activated receptor c (PPARc) target genes.
Consistently, the expression of this key transcription factor for lipogenesis was significantly reduced both on the mRNA and
protein levels. Despite b-109-apocarotenoid production, this effect of BC was absent in Bcmo1
-/- mice, demonstrating that it
was dependent on the Bcmo1-mediated production of retinoids. Our study evidences an important role of BC for the control
of body adiposity in mice and identifies Bcmo1 as critical molecular player for the regulation of PPARc activity in adipocytes
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Introduction
In mammals, b-carotene (BC) is the natural precursor for
apocarotenoids molecules including retinoids (vitamin A and its
derivatives) [1]. Two different types of BC metabolizing enzymes
have been identified that are expressed in various tissues [2-4].
The b-carotene-15,159-monooxygenase (Bcmo1) converts BC to
all-trans-retinal [5;6] and studies in knockout (Bcmo1
-/-) mice show
that Bcmo1 is the primary enzyme for retinoid production [7-9].
Besides Bcmo1, mammalian genomes encode a second BC
metabolizing enzyme known as b-carotene-99,109-dioxygenase
(Bcdo2). Bcdo2 cleaves BC at position 9,10, resulting in the
formation of one molecule b-ionone and one molecule b-109-apo-
carotenal [4].
Increasing evidence has been provided that BC-derived
apocarotenoid signaling molecule can influence adipocyte
physiology. Bcmo1 knockout mice are highly susceptible to high
fat diet-induced obesity and show increased expression of
peroxisome proliferator-activated receptor c (PPARc) regulated
genes in fat depots [7]. PPARs control the expression of genes
for lipid and glucose metabolism [10;11] and PPARc is pivotal
for adipocyte differentiation and lipogenesis in mature adipo-
cytes [12]. Bcmo1 gene expression is under the control of PPARc
[13;14] and is induced during adipocyte differentiation [15].
The primary BC cleavage product retinaldehyde has been
shown to inhibit PPARc activity both in adipocyte cell cultures
and mouse models [16]. Furthermore, evidence has been
provided that Bcmo1 plays an important role for retinoic acid
production and retinoic acid receptor (RAR) signaling in
adipocytes [15]. Retinoic acid influences adipocyte differentia-
tion [17;18] and fat deposition [19], mitochondrial uncoupling
[20;21], oxidative metabolism [22;23] and the expression of
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protein [24-27]. Part of these effects are mediated via RARs,
which upon retinoic acid binding regulate the expression of
direct target genes [28] and interfere with the activity of other
transcription factors, including early adipogenic transcription
f a c t o r ss u c ha sP P A R c [17;18]. In addition, retinoic acid may
influence PPAR-mediated responses by activating the retinoid X
receptor (RXR) moiety of permissive PPAR:RXR heterodimers
[29] and, possibly, by serving as an agonist of PPARb/d
[30;31]. Finally, BC-derived long chain apocarotenoids such as
b-apo-149-carotenal can inhibit PPARc activity and adipogen-
esis in cell culture [32]. Moreover, b-13-apocarotenone has
been shown to inhibit RXRa activity [33].
These findings implicate that a tissue-specific conversion of BC
via carotenoid-oxygenases can influence the activities of key
transcription factor that control adipocyte physiology. However,
this concept lacks experimental testing in animal models. Here we
wished to systematically analyze the effects of BC on the adipose
phenotype in mice. To genetically dissect the contributions of
Bcmo1 and Bcdo2 to this process, we used wild-type (WT) and
Bcmo1
-/- mice in this study. Our analysis included a genome wide
expression analysis of inguinal white adipose tissue (iWAT) to
identify the target genes of BC action in this tissue.
Results
Effects of dietary BC supplementation on BC and retinoid
levels in serum and adipose tissue
Five-week-old WT and Bcmo1
-/- female mice were fed a defined,
pelletized diet containing 1500 IU vitamin A/kg with (BC diet) or
without (control diet) 150 mg BC/kg diet (n=6 animals per
group). After 14 weeks, we first studied expression of Bcmo1 in
iWAT of different dietary groups and genotypes. Bcmo1 was
expressed in iWAT of WT but not Bcmo1
-/- mice (Figure 1A). We
also analyzed the mRNA expression levels of Bcdo2, which encodes
a second carotenoid metabolizing enzyme [5]. This analysis
revealed a marked up-regulation of Bcdo2 expression in iWAT of
Bcmo1-null mice, both with control and BC diet (Figure 1B).
Similar results were obtained for Bcmo1 and Bcdo2 expression in
gonadal WAT (Figure S1).
Serum and iWAT BC levels were significantly increased after
the 14 weeks of dietary intervention in all animals subjected to
BC supplementation (Figures 1C and 1E). This increase was
much more pronounced in the Bcmo1
-/- mice, in which BC
accumulation was readily evidenced by an orange coloring of the
fat depots (not shown). Serum retinol levels were similar
regardless of genotype or diet (Figure 1D). iWAT total retinol
levels (free retinol plus retinyl ester) were increased upon the BC
diet in WT but not in Bcmo1
-/- mice (Figure 1F). In Bcmo1
-/- mice
supplemented with BC, a compound that migrated shortly after
all-trans-retinol with an absorption maximum of 402 nm was
present (Fig. 1G). Spectral characteristics and retention time
indicated that this compound is b-109-apocarotenol, the corre-
sponding alcohol of the primary Bcdo2 cleavage product b-109-
apo-carotenal. To confirm this hypothesis, we used a b-109-
apocarotenal standard and reduced it to the corresponding
alcohol by BH4 treatment. In fact, this b-109-apocarotenol
standard had the same retention time and spectral characteristics
of the compound that accumulated in Bcmo1
-/- mice upon BC
supplementation (Fig 2A and 2B). Finally, we confirmed the
identity of this compound by tandem mass spectrometry as
compared b-109-apocarotenol standard substance (Fig. 2C-F).
Thus, we concluded that in WT mice supplemented BC is largely
converted to retinoids. When BC accumulated in Bcmo1
-/- mice,
it is converted in part to b-109-apocarotenal that is further
reduced to the corresponding alcohol.
Dietary BC reduces adiposity in WT mice
Bcmo1
-/- mice had a lower average body weight than WT mice
at the beginning of the study (17.360.4 g versus 18.560.2 g;
p,0.05 Student’s t test) and showed a tendency of higher body
weight gain over the 14 week experimental period (Figure 3A).
Body weight at the end of the study was comparable in all groups
(data not shown). Cumulative energy intake over the 14 week
experimental period was significantly higher in mice fed the BC
diet than in those fed the control diet, and in Bcmo1
-/- mice as
compared to WT mice (Figure 3B). Energy efficiency (body
weight gained per energy eaten) was similar among groups
(Figure 3C). Even though BC supplementation did not affect final
body weight in either genotype, it significantly decreased the
percentage of body fat (by 28%, p,0.01) in WT but not in
Bcmo1
-/- mice (Figure 3D). In WT mice, reduction of depot mass
after BC diet was evident for all three WAT depots examined
(inguinal, gonadal and retroperitoneal) (Figure 3E); no such effect
of BC on fat depots was observed in the Bcmo1
-/- mice. Leptin
levels in serum reflected changes in body adiposity, being reduced
following dietary BC supplementation in the WT mice but not in
the Bcmo1
-/- mice (Table 1). There was a direct, positive
correlation between serum leptin levels and iWAT mass
(r=0.617, p,0.001). Morphometric analysis showed that the
mean sectional area of unilocular iWAT adipocytes was reduced
after dietary BC supplementation in the WT mice (Figure 3F and
3G). Mean iWAT adipocyte area was similar in the two genotype
groups after the control diet, but significantly higher in the
Bcmo1
-/- mice after the BC diet. Circulating levels of insulin,
glucose and triacylglycerol were unaffected by diet or genotype
(Table 1).
Dietary BC results in a general down-regulation of gene
expression in adipose tissue of WT mice
To analyze the effects of BC supplementation on transcrip-
tional activities in adipose tissue in different genotypes we
performed genome-wide expression analysis of iWAT of all
individual animals. Principal component analysis of microarray
results revealed a different gene expression signature in WT and
Bcmo1-null mice, and a clear effect of dietary BC supplementation
that changed the overall gene expression signature in the WT
mice, but not in the Bcmo1-null mice (Figure 4A). From the 25139
spots with signal intensities above two times the background,
1597 positive spots were differentially expressed due to BC
supplementation in the WT mice and only 84 in the Bcmo1-null
mice (p,0.01) (Figure 4B). These 84 positive spots correspond to
81 genes, that are given in Table S1 and are likely regulated by
BC or b-109-apocarotenoid accumulation. None of the genes
affected by BC supplementation in the WT mice (p,0.01) were
affected in the Bcmo1-null mice (Figure 4B, 0 genes overlapping).
In the WT mice, genes significantly regulated (p,0.01) by BC
supplementation appeared to differ most in expression as
compared to the other three groups; WT control diet, Bcmo1
-/-
control diet and Bcmo1
-/- BC diet (Figure 4D). Remarkably, upon
BC supplementation, 87% of the genes affected in WT mice were
found to be down-regulated (Figures 4C and 4D). Pathway
analysis using Metacore showed that genes encoding components
of lipid and glucose metabolism-related pathways (including
cholesterol biosynthesis, fatty acid metabolism, glycerophospho-
lipid metabolism, pentose phosphate pathway, pyruvate metab-
olism and glycolysis/ gluconeogenesis) as well as ATP synthesis
and oxidative phosphorylation were among the most affected
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larisation and adipose tissue expansion [34–35], we specifically
examined changes in the expression of angiogenesis-related
genes. As expected, BC supplementation triggered a generalized
down-regulation of these genes in the WT mice, but not in the
Bcmo1
-/- mice (Table S3).
Figure 1. Serum and inguinal white adipose tissue levels of b-carotene, retinoids and apocarotenoids. (A, B) b-carotene -15, 159-
monoxygenase (Bcmo1) and b-carotene 99,1 0 9-dioxygenase (Bcdo2) mRNA levels in inguinal white adipose tissue (iWAT) of wild-type (WT) and
Bcmo1-null (Bcmo1
-/-) mice after 14 weeks on a control diet (open bars) or a b-carotene-enriched diet (black bars). Quantitative real-time PCR was
used to determine normalized gene expression levels. (C-G) b-carotene, retinol and 109 b-apocarotenol levels in serum and iWAT of WT and Bcmo1
-/-
mice after 14 weeks on a control diet (open bars) or a b-carotene-enriched diet (black bars). b-carotene, retinol and b-109-apocarotenol were
determined by HPLC (see Materials and Methods). Total retinol refers to free retinol plus retinyl esters. Data in (A to G) are the mean 6 SEM of 6
animals per group; n.d. non-detectable; GxD, interaction between genotype and diet in two-way ANOVA analysis (p,0.05); G, genotype effect in two-
way ANOVA analysis (p,0.05); *, p,0.05 in Student’s t test, BC diet versus control diet.
doi:10.1371/journal.pone.0020644.g001
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genes in adipose tissue of WT mice
A general effect of BC supplementation in reducing global
transcriptional activity in iWAT of WT mice suggested that the
activity of a master control transcription factor of adipose tissue
biology was affected. In this context, a batch promoter analysis with
Eldorado coupled to matinspector (Genomatix Suite) revealed that
54% of the top 50 down-regulated genes in iWAT of BC
supplemented WT mice harbored a putative PPAR response element
in their promoter region (p value: 1.33e
26)w i t ha tl e a s t8 5 %
homology with the matrix similarity defined by Genomatix (Table 2).
Interestingly, the same kind of analysis in iWAT of BC supplemented
Bcmo1
-/- micerevealed thatthepresenceofputativePPARresponsive
element was not significant (p value: 0.81). Microarray results
indicated that iWAT gene expression of PPARc and its heterodi-
meric partner RXRa were significantly decreased following BC
supplementation in the WT mice (–1.75 and 21.57 fold-change,
respectively, p,0.05), but not in the Bcmo1
-/- mice. Q-PCR analysis
confirmed the microarray results and thus down-regulation of the
mRNA expression levels of PPARc and RXRa after BC supple-
mentation in iWAT of WT mice, but not of Bcmo1
-/- mice (Figure 5A
and 5B). Additionally, PPARc protein expression levels in iWAT
followed the same pattern as the mRNA levels, as indicated by
immunoblotting results (Figure 5D). In contrast, iWAT mRNA levels
of CYP26a1, a retinoic acid hydroxylase that is transcriptionally
induced by retinoic acid in a strictly RAR-dependent manner
[36;37], were increased by 138% after BC supplementation in the
WT mice, but not in the Bcmo1
-/- mice (Figure 5E), suggesting a
Bcmo1-dependent enhancement of retinoic acid signalling in iWAT
following chronic BC supplementation. Finally, to provide direct
evidence for down-regulation of PPARc activity after BC supple-
mentation in the WT mice, we determined iWAT mRNA levels of
L P L ,aw e l l - k n o w nt a r g e to fP P A R c:RXRa,b yQ - R T - P C R .A s
shown in Fig. 5C, LPL mRNA levels were significantly decreased in
WT mice upon BC supplementation. Changes in gene expression of
PPARc,R X R a and LPL in the gonadal fat depot followed the same
pattern as in the inguinal depot (Figure S1).
Discussion
Here we analyzed the effects of dietary BC on whole-body
adiposity and adipose tissue physiology. We supplemented WT
and Bcmo1
-/- mice with BC and compared them to non-
supplemented littermates. Our results revealed a Bcmo1-depen-
dent, adiposity reducing effect of BC supplementation, as percent
Figure 2. b-109-apocarotenol is the major b-carotene cleavage product in Bcmo1
-/- mice. HPLC-profile at 420 nm of (A) the synthetic b-109-
apocarotenol standard and (B) a lipid extract of iWAT of BC supplemented Bcmo1
-/- mice. Insets show the spectral characteristics of the b-109-
apocarotenol standard (peak 1) as compared to peak 19.( C, D) Single extracted ion chromatograms for b-109-apocarotenol standard (m/z =361.42;
peak 1 and 19). (E, F) Fragmentation pattern of a parent ion selected at m/z =361.42 are identical for the b-109-apocarotenol standard (peak 1) and
peak 19.
doi:10.1371/journal.pone.0020644.g002
Beta-Carotene Reduces Adiposity
PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e20644body fat, adipose depot mass, iWAT adipocyte size and leptin
serum levels were all significantly reduced after BC supplemen-
tation in the WT mice, but not in the Bcmo1
-/- mice (Figure 3).
Reduced adiposity in WT mice after BC supplementation was not
associated with adverse effects on blood parameters measured such
as increased circulating triacylglycerol levels. Moreover, no
harmful effects of BC supplementation on parameters such as
body weight gain, food intake, or lung tissue histology were
observed in the animals (this work and [38]). Although relatively
low dietary vitamin A was fed, blood retinol levels were well
maintained and within the expected range for adult mice in the
different genotypes and supplementation groups (Figure 1D).
Additionally, stored retinol was found in the adipose tissue
(Figure 1F) and in the liver (data not shown), indicating no gross
changes in vitamin A homeostasis in animals of different
supplementation groups.
Microarray analyses revealed that BC supplementation altered
the overall iWAT gene expression signature in WT mice but not in
Bcmo1
-/- mice. Strikingly, none of the genes altered in its
expression levels upon BC supplementation in the WT mice
Figure 3. Supplemetation of b-carotene alters body adiposity in wild-type mice. (A) Effects of dietary b-carotene supplementation on body
weight gain, (B) cumulative energy intake, (C) energy efficiency, (D) adiposity index, (E) adipose depot weight, and (F) inguinal adipocyte mean
sectional area, in wild-type (WT) and Bcmo1-null (Bcmo1
-/-) mice. In (G), micrographs of sections of inguinal fat in the four groups are shown (The
scale bar gives 100 mm). Data in (A to E) are the mean6SEM of 6 animals per group, and data in (F) of 3 animals per group Open bars, animals on the
control diet; black bars, animals on the b-carotene-enriched diet. Body weight gain, cumulative energy intake and energy efficiency over the entire 14
week experimental period are shown. Adiposity index corresponds to the sum of all entirely dissected white adipose tissue depots (gonadal, Gon;
inguinal, Ing; and retroperitoneal, Retr), expressed as percentage of the animal body weight (BW).. G, genotype effect in two-way ANOVA analysis
(p,0.05); D, effect of diet in two-way ANOVA analysis (p,0.05);*, p,0.05 in Student’s t test, BC diet versus control diet.
doi:10.1371/journal.pone.0020644.g003
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supplementation led to a general down-regulation of gene
expression in iWAT of WT mice. This finding indicated that the
activity of major transcriptional regulator of iWAT was affected by
BC supplementation. Microarray, Q-PCR and immunoblotting
analysis consistently confirmed a reduction of PPARc expression
Table 1. Fed blood parameters in wild-type and Bcmo1
-/- mice following control and b-carotene enriched diet.
WT control diet WT BC diet Bcmo1
-/- control diet Bcmo1
-/- BC diet Anova
Glucose (mg/dL) 211622 220692 4 2 612 248621
Triacylglycerol (mg/mL) 0.3160.05 0.3060.03 0.3160.05 0.4060.08
Insulin (ng/mL) 0.4760.20 0.3660.10 0.4960.15 0.5960.18
Leptin (ng/mL) 9.6361.69 4.0960.59* 6.7261.74 7.3361.59 GxD
Analysis were carried out in wild-type (WT) and Bcmo1
-/- female mice fed for 14 weeks a control diet or a b-carotene-enriched diet (BC diet), starting at 5 weeks of age.
Data are the mean 6 SEM of 6 animals per group. *, p,0.05 in Student’s t test, BC diet versus control diet; GxD, interaction between genotype and diet in two-way
ANOVA analysis (p,0.05).
doi:10.1371/journal.pone.0020644.t001
Figure 4. Supplementation of b-carotene alters gene expression profiles in wild-type but not in Bcmo1
-/- mice. (A) Principal component
analysis of transcriptional profiles in inguinal white adipose tissue of female wild-type (circles) and Bcmo1
-/- (squares) mice fed the control diet (open
symbols) or the b-carotene diet (closed symbols). Genome-wide expression profiles were obtained using the 4644 k Agilent whole mouse genome
microarrays for each animal in the experiment (n=6 per group). (B) Venn diagram representing the number of significantly regulated genes (p,0.01)
due to BC supplementation in wild-type (WT) and in Bcmo1-null (Bcmo1
-/-) mice and the number of significantly regulated genes regardless of
genotype (overlap). (C) Volcano plot representing the effect of BC supplementation on gene expression in WT mice, with the fold-change on the x-
axis and the corresponding Student’s t-test p-value on the y-axis. Every spot is a single gene and in black are all genes with a p-value ,0.01. (D) Heat
map representing the expression level of all genes regulated by BC with a Student’s t-test p,0.01 in the WT mice in all four groups; WT control (Co)
diet, WT BC diet, Bcmo1
-/- control diet and Bcmo1
-/- BC diet. Relative expression of every single gene was compared to gene expression in WT mice on
the control diet and consequently, gene expression of every single gene in WT mice on the control diet was set to 1.0.
doi:10.1371/journal.pone.0020644.g004
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genes in inguinal white adipose tissue of wild-type mice after b-carotene supplementation.
Gene Gene name p value fold-change putative PPRE
Npr3 natriuretic peptide receptor 3 0.00033 24.18 Yes
Mosc1 MOCO sulphurase C-terminal domain containing 1 0.00234 23.26 Yes
Dnmt3l DNA (cytosine-5-)-methyltransferase 3-like 0.00452 23.14
Scd2 stearoyl-Coenzyme A desaturase 2 0.00606 23.02 Yes
Lep Leptin 0.00106 22.84
Rbp4 retinol binding protein 4, plasma 0.00030 22.80 Yes
Pnpla3 patatin-like phospholipase domain containing 3 0.00098 22.78
Dgat2 diacylglycerol O-acyltransferase 2 0.00166 22.68 Yes
Slc2a5 solute carrier family 2 (facilitated glucose transporter), member 5 0.02198 22.60
Fads3 fatty acid desaturase 3 0.00027 22.52 Yes
Alb1 albumin 1 0.00058 22.51 Yes
Mod1 malic enzyme, supernatant 0.00280 22.46 Yes
Gsta3 glutathione S-transferase, alpha 3 0.00075 22.46
Mogat2 monoacylglycerol O-acyltransferase 2 0.00408 22.44 Yes
Fabp5 fatty acid binding protein 5, epidermal 0.00026 22.37
Elovl6 ELOVL family member 6, elongation of long chain fatty acids (yeast) 0.01515 22.36 Yes
Ela1 elastase 1, pancreatic 0.00155 22.35 Yes
Cav1 caveolin, caveolae protein 1 0.00083 22.35
Cspg3 chondroitin sulfate proteoglycan 3 0.02156 22.33
Apol6 apolipoprotein L, 6 0.00167 22.33 Yes
LOC676546 similar to monocyte to macrophage differentiation-associated 0.00024 22.32 Yes
Sncg synuclein, gamma 0.00155 22.32
Ppp2r5b protein phosphatase 2, regulatory subunit B (B56), beta isoform 0.00294 22.31
Tkt Transketolase 0.01153 22.31
Ntsr2 neurotensin receptor 2 0.00032 22.31 Yes
Acss2 acyl-CoA synthetase short-chain family member 2 0.01181 22.28 Yes
Mid1ip1 Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) 0.03037 22.21 Yes
Retn Resistin 0.00282 22.19
Lpgat1 lysophosphatidylglycerol acyltransferase 1 0.00024 22.19 Yes
Lctl lactase-like 0.00010 22.18 Yes
Slc6a13 solute carrier family 6 (neurotransmitter transporter, GABA), member 13 0.00394 22.17
Comt catechol-O-methyltransferase 0.00946 22.17
Thbd Thrombomodulin 0.01020 22.17 Yes
Orm2 orosomucoid 2 0.00026 22.14 Yes
Orm1 orosomucoid 1 0.00018 22.13 Yes
Lrrc39 leucine rich repeat containing 39 0.00130 22.12
Sc5d sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) 0.00095 22.12
Fabp4 fatty acid binding protein 4, adipocyte 0.00690 22.11 Yes
Lss lanosterol synthase 0.00103 22.10
Odz4 odd Oz/ten-m homolog 4 (Drosophila) 0.00063 22.10
Slc9a2 solute carrier family 9 (sodium/hydrogen exchanger), member 2 0.00214 22.10 Yes
Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 0.00010 22.10 Yes
Cpa2 carboxypeptidase A2, pancreatic 0.00157 22.10
Timp4 tissue inhibitor of metalloproteinase 4 0.01792 22.09
Slc2a4 solute carrier family 2 (facilitated glucose transporter), member 4 0.01228 22.09 Yes
Adamts5 a disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 5 (aggrecanase-2)
0.00287 22.08
Kcnj14 potassium inwardly-rectifying channel, subfamily J, member 14 0.00022 22.07
Slc16a12 solute carrier family 16 (monocarboxylic acid transporters), member 12 0.00221 22.07 Yes
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top 50 BC down-regulated genes in wild-type mice showed that
more than 50% contained a PPAR response element (Table 2).
The p value associated (1.33e
26) strongly supported the impor-
tance of PPARc within this gene set, since it represent the
probability to obtain an equal or greater number of sequences with
a match in a randomly list of genes. Interestingly, such result was
not reproduced in the Bcmo1
-/- mice (p value 0.81; not significant)
underlying the key role of this enzyme in the repression of PPARc
activity by BC. Thus, the reduction of PPARc activity and the
down-regulation of its target genes likely explain the reduced
adiposity of WT mice upon BC supplementation.
Gene Gene name p value fold-change putative PPRE
Dbi diazepam binding inhibitor 0.00384 22.06 Yes
Fasn fatty acid synthase 0.00220 22.06
Batch promoter analysis was performed with Eldorado coupled to matinspector (Genomatix Suite). Yes in the right column indicates the presence in the corresponding
gene promoter of a putative PPAR response element (PPRE) with at least 85% homology with the matrix similarity defined by Genomatix.
doi:10.1371/journal.pone.0020644.t002
Table 2. Cont.
Figure 5. b-carotene supplementation reduces PPARc expression both on the mRNA and protein level. (A) PPARc mRNA levels, (B) RXRa
mRNA levels, (C) lipoprotein lipase (LPL) mRNA levels, (D) PPARc protein levels and (E) Cyp26a1 mRNA levels in inguinal white adipose tissue of wild-
type (WT) and Bcmo1-null (Bcmo1
-/-) mice after 14 weeks on a control diet (open bars) or a b-carotene -enriched diet (black bars). Quantitative real-
time PCR was used to determine normalized gene expression levels as described in Materials and Methods. Immunoblotting was used to determine
expression levels of PPARc and b-actin, which was used as internal control for equal loading and blotting; shown at the bottom of (D)i sa
representative immunoblot for the two proteins. Data in (A to E) are the mean 6 SEM of 6 animals per group. G, effect of genotype in two-way
ANOVA analysis (p,0.05); *, p,0.05 in Student’s t test, BC diet versus control diet.
doi:10.1371/journal.pone.0020644.g005
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production which can be converted to retinol and retinyl ester for
storage and to retinoic acid. Enzymes catalyzing these reactions
are expressed in adipocytes [7;16]. Retinoids such as retinoic acid
and retinaldehyde are ligands for nuclear receptors including
RARs and PPARs that help control adipogenesis and adipocyte
metabolism. Treatment with retinoic acid has been shown to
inhibit differentiation of pre-adipose cells in culture by blocking
PPARc induction in an RAR-mediated manner [18;39], and to
result in vivo in mice in reduced PPARc expression levels in WAT
[19] and reduced whole body adiposity [19;31]. Moreover, a
recent study showed that BC, but not retinol, decreases PPARc
and reduces lipid storage capacity in mature white adipocytes in
culture [15]. This effect involves production of retinoic acid from
BC, is blocked by a Bcmo1 chemical inhibitor (fenretinide), and is
dependent on RARs [15]. Importantly, BC was accumulated
following BC diet in serum and tissues of WT mice (Figure 1C and
1E), suggesting that not all BC undergoes intestinal cleavage in
WT mice. Thus, an adipose tissue-specific, Bcmo1-dependent
production of retinoids, such as retinoic acid, from BC might
explain the down-regulation of iWAT PPARc expression levels
and the overall changes in iWAT gene expression patterns and
adiposity-related end-points observed in this work in WT mice
following chronic exposure to a BC-enriched diet. The involve-
ment of RAR-signalling is sustained by the CYP26a1 gene-
expression data showing increased expression of this retinoic acid
target gene following BC supplementation selectively in the iWAT
of WT mice (Figure 5E). Additionally, iWAT mRNA levels of
some other genes for which there is evidence of transcriptional up-
regulation or down-regulation in response to retinoic acid were
significantly increased and decreased, respectively, following BC
supplementation in the WT mice, but not in the Bcmo1-null mice
(microarray data shown in Table S4), including leptin. Leptin
expression has been shown to be decreased by retinoic acid [24–
27] and blood levels of this adipokine were significantly reduced in
WT mice supplemented with BC.
Interestingly, expression of the Bcdo2 gene was up-regulated in
iWAT of Bcmo1-null mice, both under control and BC diet
(Figure 1B). In fact, relatively large amounts of b-109-apocarotenol
became detectable in WAT of Bcmo1
-/- mice upon BC
supplementation. This compound derives by the reduction of the
primary BC cleavage product b-109-apo-carotenal. It has been
reported that apocarotenoids such as b-14-apo-carotenal can
repress PPARc - and RXR-mediated responses in cell culture
[32]. However, we found not much evidence that apocarotenoid
formation in Bcmo1
-/- mice influenced adipocyte physiology. Our
results indicate that the effects of BC on adipocyte biology are
clearly dependent on Bcmo1, as those effects were not found in
Bcmo1-deficient animals that express Bcdo2.
In summary, this study revealed a Bcmo1-dependent, adiposity
reducing effect of long-term BC supplementation in mice. In this
context, we provide evidence that BC-derived retinoids influence
adipocyte physiology. Bcmo1 is a PPARc target gene [13], and our
analysis indicates that the Bcmo1-dependent, adiposity-reducing
effect of BC is mediated by a reduction of PPARc activity in
adipocytes. Thus, our findings establish Bcmo1 as key component
for the crosstalk between RAR- and PPARc-signaling pathways in
the control of body adiposity.
Our results may also have implications in the context of the
current obesity pandemics. There is evidence of an impact of BC
and vitamin A status on parameters related to adiposity in humans
[40]. Circulating BC levels are inversely correlated with risk of
human type 2 diabetes, a pathology associated with obesity [41–
44] . Additionally, reduced plasma levels of carotenoids, including
BC, are commonly found in obese children [45]. Genetic
polymorphisms in the Bcmo1 gene have been described that alter
the activity of the encoded human protein [46;47]. Our work
suggests that BC intake may have different consequences on body
adiposity in subjects carrying different Bcmo1 functional gene
variants. Thus, the involvement of BC and Bcmo1 in human
obesity deserves further research.
Materials and Methods
Animals and diets
The animal experiment was conducted according to accepted
standards of humane care and use of laboratory animals, and was
approved by the bioethical committee of the University of Freiburg
(Az.: 35/9185.81/G-07/30). C57/BL6;129Svj-Bcmo1
tm1Dnp
(Bcmo1
-/-) mice previously described by Hessel et al. [7] and mixed
background F1 generation of C57/BL6;129Svj mice as WT
controls were used. During the breeding and weaning periods and
up to 5 weeks of age all mice were maintained on breeder chow
containing 14000 IU vitamin A/kg diet (Provimi Kliba AG,
Kaiseraugst, Switzerland). Five-week-old WT and Bcmo1
-/- female
mice were fed a defined, pelletized diet containing 1500 IU vitamin
A/kg and 10% energy as fat, with (BC diet) or without (control diet)
150 mg BC/kg diet (n=6 animals per group) for 14 weeks, after
which they were euthanized. Detailed composition of these diets is
shown in Table 3. A relatively low dose of dietary vitamin A was
used to maximize intestinal BC absorption, which can be repressed
by preformed vitamin A [48]. The dose used was previously shown
to be sufficient to maintain vitamin A homeostasis while allowing
tissue BC accumulation both in WT and Bcmo1
-/-mice [9]. The
experimental diets were prepared by Research Diets, Inc (New
Brunswick, NJ, USA) by cold extrusion so as to protect BC from
heat treatment and incorporatinga water-soluble formulation in the
form of beadlets containing BC, DL-a-tocopherol, ascorbyl
palmitate, corn oil, fish gelatin, sucrose and corn starch. The
control diet contained control beadlets devoid of BC, but with all
other ingredients. All beadlets were kindly provided by DSM
Nutritional Products Ltd (Basel, Switzerland). Mice were main-
tained under environmentally controlled conditions (24uC, 12 h/
12 h light/dark cycle) in groups of 3 animals per cage and with ad
libitum access to feed and water. Body weight and food intake were
determined twice per week (3 and 4 days intervals). Energy intake
was estimated on a per-cage basis from the actual amount of food
consumed by the animals and its caloric equivalence (16 MJ/kg for
both control and BC diet). On the day of the necropsy, the animals
were sacrificed according to the animal protocol of the University of
Freiburg (Germany). First, animals were subjected to inhalation of
isofluran. Then, 100–150 mg/kg KGW Ketamin (Ketamin 10%,
Essex) and 5–10 mg/kg KGW Xylazin (Rompun 2 %, Bayer) were
injectedintraperitoneally.Bloodwasdrawnfromthevenacava,and
animals were then sacrificed by cervical dislocation. Inguinal
(iWAT), gonadal (periovarian) and retroperitoneal white adipose
tissue(WAT) depotswereexcisedintheirentiretyaccordingtoCinti
[49], weighed, snap-frozen in liquid nitrogen and stored at –80uC
until analysis. The continuous subcutaneous fat depot comprising
the dorsolumbar and inguinal areas was taken as iWAT. The
combined mass of all WAT pads taken expressed as a percentage of
body weight was used as adiposity index. For three animals in each
group, one entire iWAT lobule was fixed for histological studies.
Histology and immunohistochemistry
Entire iWAT lobules were fixed by immersion in the perfusion
fixative (4% paraformaldehyde in 0.1 M sodium phosphate buffer,
pH 7.4) overnight at 4uC, dehydrated, cleared and then paraffin-
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of the wider surface. 3 mm-thick sections at the same level were
obtained and stained with hematoxylin/eosin for morphometric
analysis, performed by digital acquisition of adipose tissue areas
(Digital Still Camera DXM 1200 and NIKON 6000 Eclipse
Microscope). Two histological sections were counted per mouse.
Serum parameters
Commercial enzymatic colorimetric kits were used for the
determination of circulating levels of triacylglycerol (Triglyceride
(INT) 20, Sigma Diagnostics, St Louis, MO, USA) and glucose (D-
Glucose UV-method, Roche Biopharm GmbH, Darmstadt,
Germany). Serum levels of leptin and insulin were measured as
described before [50] with some minor differences. Briefly, sera
were diluted 4x in High Performance ELISA buffer (Sanquin,
Amsterdam, The Netherlands) before adipokine analyses using the
mouse serum adipokine Lincoplex Kit (Linco Research, Nuclilab,
Ede, The Netherlands). The assays were conducted according to
the manufacturer’s protocol and measured using the Bio-PLex
(Bio-Rad, Venendaal, The Netherlands) system with Bio-Plex
software. All individual samples were analyzed in duplicate and
averaged.
Analysis of retinoids, apocarotenoids, and carotenoids
Retinoids and carotenoids were extracted from serum under
dim red safety light (600 nm) as described previously [7]. Adipose
tissue (,40 mg) was incubated with 100 mL of 12% pyrogallol in
ethanol, 200 mL of 30% KOH in water and 1 ml ethanol for 2 h
at 37uC. After saponification, 1 ml H2O was added. The samples
were extracted with 3 ml of ether/hexane (2:1, stabilized with 1%
ethanol) twice, and diluted with 2 ml H2O and 2 ml ethanol.
After centrifugation for 5 min at 8006 g, the organic layer was
collected. The extract was evaporated in a Speedvac and
dissolved in HPLC solvent. HPLC separation of carotenoids
and retinoids and quantification of peak integrals was performed
as described previously [6]. Solvents for HPLC and extraction
were purchased in HPLC grade from Merck (Darmstadt,
Germany). b-109-apocarotenal was a gift of Dr. Hansgeorg Ernst
(BASF, Germany). For b-109-apocarotenol production, the
standard was dissolved in 1 ml ethanol and reduced with BH4
on ice. After 20 min, reaction products were extracted upon
addition of 1 ml H2O with 1 ml hexanes. The organic phase was
dried with a speedvak and redissolved in hexanes and subjected
to HPLC analysis. The identity of b-109-apocarotenol was further
confirmed by LC/MS. The saponified lipophilic extract from
iWAT was injected onto a Zorbax Sil column (Agilent
Technologies, Santa Clara, CA) equilibrated with 90 % hexane
and 10 % acetylacetate (v:v). The eluant was directed into LXQ
mass spectrometer through an atmospheric pressure chemical
ionization source (Thermo Scientific Waltham, MA) working in a
positive mode. b-109-apocarotenol was identified based on its
molecular mass (m/z =361.42 [MH]
+) and a fragmentation
pattern of the parent ion identical with that of the b-109-
apocarotenol standard.
RNA isolation
WAT was homogenized in liquid nitrogen using a liquid
nitrogen cooled mortar and pestle. Total RNA was isolated using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) followed by
purification using RNeasy columns (Qiagen, Venlo, The Nether-
lands) according to the instructions of the manufacturer. RNA
concentration and purity were measured using the Nanodrop
spectrophotometer (ND-1000, Isogen Life Science, Maarssen,
The Netherlands). Approximately 20 mg of total RNA was
isolated from each WAT depot. A260/A280 ratios were above
2 and A260/A230 ratios were above 1.9 for all samples,
indicating good RNA purity. RNA degradation was checked
using StdSense Chips (Biorad) and no apparent RNA degrada-
tion was seen.
Q-PCR analysis
cDNA was prepared by reverse transcription of 1 mg total RNA
using random hexamers as primers with M-MLV reverse
transcriptase (Invitrogen). The expression of selected cDNAs was
analyzed by real-time quantitative PCR, as reported previously
[51]. Reactions were performed in duplicate with a Stratagene
MX3005P apparatus (Stratagene, Amsterdam, The Netherlands)
using SYBR green kit (Eurogentec, Angers, France), according to
the manufacturer instructions. Primers used were as follows: for
PPARc,5 9-CAA GAA TAC CAA AGT GCG ATC AA-39 and
Table 3. Composition of the control and beta-carotene (BC)
diets.
Control diet BC diet
Macronutrients
Protein (g/100 g) 19.2 19.2
Carbohydrate (g/100 g) 67.2 67.2
Fat (g/100 g) 4.3 4.3
Kcal/g (MJ/kg) 3.84 (16) 3.84 (16)
Calories from protein (%) 20 20
Calories from carbohydrate (%) 70 70
Calories from fat (%) 10 10
Ingredients (g/Kg)
Casein, 30 mesh 189 189
L-Cystine 2.8 2.8
Corn Starch 298 298
Maltodextrin 10 33 33
Sucrose 331 331
Cellulose, BW200 47 47
Soybean Oil 24 24
Lard 19 19
Salt Mix, S10026 9.5 9.5
DiCalcium Phosphate 12 12
Calcium Carbonate 5.2 5.2
Potassium Citrate, 1 H2O 16 16
Vitamin Mix V13001 with no added vitamin A 9.5 9.5
Vitamin A (retinol acetate, 500,000 IU/g) 0.003 0.003
Choline bitartrate 1.9 1.9
BC beadlets with 100 mg BC/g* 0 1.5
Control beadlets without BC 1.5 0
FD&C Yellow Dye #5 0 0.024
FD&C Red Dye #40 0.047 0
FD&C Blue Dye #1 0 0.024
BC beadlets contained BC, DL-a-tocopherol, ascorbyl palmitate, corn oil, fish
gelatin, sucrose and corn starch. Control beadlets were devoid of BC, but with
all other ingredients. All beadlets were kindly provided by DSM Nutritional
Products Ltd (Basel, Switzerland). The experimental diets were prepared by
Research Diets, Inc (New Brunswick, NJ, USA) by cold extrusion so as to protect
BC from heat treatment.
doi:10.1371/journal.pone.0020644.t003
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RXRa,5 9-GCC ATC TTT GAC AGG GTG CTA-39 and 59-
CTC CGT CTT GTC CAT CTG CAT-39; for lipoprotein lipase
(LPL), 59-GGC CAG ATT CAT CAA CTG GAT-39 and 59-
GCT CCA AGG CTG TAC CCT AAG-39; for b-carotene 99,
109-dioxygenase (Bcdo2), 59-CCT GGT GAG TAT TCC CTC
ACA-39 and 59-TCT CAA CTG TTTCTG CGT TTC-39; and
for Bcmo1, 59-TCT GAG TTC GGA ACC ATG GC-39 and 59-
GTG TGA GAC AAG TAG GAG AAA GCT-39. The relative
levels of mRNA were calculated using the comparative DDCt
method. 18S rRNA (59- CGC CGC TAG AGG TGA AAT TCT-
39 and 59- CAT TCT TGG CAA ATG CTT TCG-39) was used
as reference gene. For CYP26a1 mRNA quantification, the
TaqMan Gene Expression Assay Mm00514486-s1 was used
together with the assay Mm00507222-s1 for 18S rRNA (Applied
Biosystems, Courtaboeuf, France).
Western blot analysis
For PPARc determination in iWAT, 100 mg of total protein
from each animal tissue was fractionated in SDS-polyacrylamide
(12% acrylamide) and then electroblotted to a PVDF membrane.
Membranes were blocked in fat-free milk (5%) dissolved in Tris
buffered saline-Tween, washed and incubated overnight at 4uC
with anti-mouse PPARc (Abcam, Cambridge, MA) diluted 1:500.
As a protein loading control, b-actin (Cell Signalling, Boston, MA)
diluted 1:1000 was used. Secondary antibody (1:5000) was
horseradish peroxidase-conjugated anti-rabbit IgG (Promega,
Madison, WI). Immunoblots were developed with the ECL system
(Amersham Biosciences) and scanned. Quantification of bands was
performed by the ImageJ (Java).
Microarray hybridization procedure
The 4 x 44 k Agilent whole mouse genome microarrays
(G4122F, Agilent Technologies, Inc. Santa Clara, CA, USA)
were used and microarray hybridization was performed essen-
tially according to the manufacturer’s protocol. In brief, cDNA
was synthesized out of 1 mg iWAT RNA using the Agilent Low
RNA Input Fluorescent Linear Amplification Kit for each animal
without addition of spikes. Thereafter samples were split in 2
equal amounts, to synthesize Cyanine 3-CTP (Cy3) and Cyanine
5-CTP (Cy5) labeled cRNA using half the amounts as indicated
by the manufacturer per dye (Agilent Technologies) and as has
been assessed previously [50]. Labeled cRNA was purified using
RNeasy columns (Qiagen). Yield, A260/A280 ratio and Cy3 or
Cy5 activity were examined for every sample on the nanodrop.
All samples met the criteria of a cRNA yield higher than 825 ng
and a specific activity of at least 8.0 pmol Cy3 or Cy5. 1200 ng of
every Cy3 labeled cRNA sample was pooled and used as a
common reference pool. Individual 825 ng Cy5-labeled cRNA
and 825 ng pooled Cy3-labeled cRNA were fragmented in 1x
fragmentation and 1x blocking agent (Agilent Technologies) at
60uC for 30 minutes and thereafter mixed with GEx Hybridiza-
tion Buffer HI-RPM (Agilent Technologies) and hybridized in a
1:1 ratio at 65uC for 17 h in an Agilent Microarray hybridization
chamber rotating at 4 rpm. After hybridization slides were
washed according to the wash protocol with Stabilization and
Drying solution (Agilent Technologies). Arrays were scanned at
an Agilent scanner with 10% and 100% laser power intensities
(Agilent Technologies).
Data analyses and statistical methods
Signal intensities for each microarray spot were quantified
using Feature Extraction 9.1 (Agilent Technologies). Median
density values and background values of each spot were
extracted for both the experimental samples (Cy5) and the
reference samples (Cy3). Quality control was performed
visually, by using Quality control graphs from Feature
extraction and M-A plots and boxplots were made using
limmaGUI in R (Bioconductor) [52] for every microarray. Data
were imported into GeneMaths XT (Applied Maths, Sint-
Martens-Latem, Belgium). Spots with a Cy5 and Cy3 signal
twice above background were selected and log transformed.
31295 spots had at least a 2-fold signal to noise ratio. The Cy5
signal was normalized against the Cy3 intensity as described
before [53]. P-values for differential expressions were calculated
between 2 groups using t-test statistics on log intensity values.
Changes were considered statistically different at p,0.05.
Vulcano plots were made using Graphpad Prism 5.0.2 (La Jolla,
CA) with all spots or a selection of spots. Heatmapping and
hierarchical clustering was performed in GeneMathsXT
(Applied Maths, St.Martens Lathem, Belgium). Pathway
analysis was performed using MetaCore (GeneGo Inc, St.
Joseph, MI, USA). Promoter analysis and the literature based
n e t w o r kw e r ep e r f o r m e dw i t ht h eG e n o m a t i xs u i t e( G e n o m a t i x
Software GmbH, Germany). Biochemical and biometric
parameters in Figures 1, 2, and 4 are presented as means 6
SEM. Statistical significance of effects on these parameters was
assessed by two-way ANOVA and two-tailed Student’s t test
using SPSS 14.0 for windows (SPSS, Chicago, IL, USA), with
threshold of significance set at p,0.05. Microarray data has
been submitted in a MIAME compliant form to Gene
Expression Omnibus (GEO) data base of the National Center
of Biotechnology Information (NCBI),, and is accessible
through GEO series accession number GSE27271 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27271).
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Figure S1 (A) PPARc mRNA levels, (B) RXRa mRNA levels, (C)
lipoprotein lipase (LPL) mRNA levels, (D) Bcmo1 mRNA levels and
(E) Bcdo2 mRNA levels in gonadal white adipose tissue of wild-type
(WT) and Bcmo1-null (Bcmo1
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